Page 2 - James Darecca News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from James darecca. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In James Darecca Today - Breaking & Trending Today

TherapeuticsMD, Inc. (TXMD) Q1 2021 Earnings Call Transcript


Operator
Good morning, ladies and gentlemen. Thank you for joining us for TherapeuticsMD first-quarter 2020 financial results conference call. [Operator instructions] I would now like to turn the call over to TherapeuticsMD s vice president of investor relations, Nichol Ochsner. Nichol?
Nichol Ochsner
Vice President, Investor Relations
Good morning, everyone. Thank you for joining today to discuss our first-quarter financial results and business update. This morning, TherapeuticsMD issued a press release announcing our first-quarter financial results. The press release is available on the company s website therapeuticsmd.com and the Investors and Media section.
On today s call from TherapeuticsMD are Chief Executive Officer Robert Finizio, Chief Financial Officer James D Arecca, Chief Commercial Officer Dawn Halkuff, and Chief Strategy and Performance Officer Mitchell Krassan. I would like to remind everyone that certain statements made during this conferenc ....

Devin Geiman Guggenheim , Rob Finizio , Douglas Tsao , Robert Finizio , Mitchell Krassan , Louise Chen , Nichol Ochsner , James Darecca , Dana Flanders , Jen Kim Cantor Fitzgerald , Cantor Fitzgerald , Therapeuticsmd Inc , Chief Executive Officer Robert Finizio , Chief Financial Officer Jamesd Arecca , Chief Commercial Officer Dawn Halkuff , Chief Strategy , Performance Officer Mitchell , Medical Necessity , Affordable Care , Vagina Appreciation Day , Orange Book , Orange Book Listed , Long May She Reign , Jamesd Arecca , டக்ளஸ் ட்‌ஸ்ம் , லூயிஸ் சென் ,

TherapeuticsMD, Inc. (TXMD) Q4 2020 Earnings Call Transcript


Operator
Good morning, ladies and gentlemen. Thank you for joining us for TherapeuticsMD fourth-quarter 2020 financial results conference call. [Operator instructions] I would now like to turn the call over to TherapeuticsMD s Vice President of Investor Relations Nichol Ochsner. Nichol?
Nichol Ochsner
Vice President, Investor Relations
Thank you. Good morning, everyone. Thank you for joining today to discuss our fourth-quarter financial results and business update. This morning, TherapeuticsMD issued a press release announcing our fourth-quarter financial results.
The press release is available on the company s website, therapeuticsmd.com in the investors and media section. On today s call from TherapeuticsMD are Chief Executive Officer Robert Finizio, Chief Financial Officer James D Arecca, Chief Commercial Officer Dawn Halkuff, and Chief Strategy and Performance Officer Mitchell Krassan. I would like to remind everyone that certain statements made during t ....

Devin Geiman Guggenheim , Rob Finizio , Douglas Tsao , Whitney Cummings , Robert Finizio , Mitch Krassan , Mitchell Krassan , Louise Chen , Annabel Samimy , Nichol Ochsner , James Darecca , Dana Flanders , Louise Chen Cantor Fitzgerald , Pop Council , Annabel Samimy Stifel Financial Corp , Therapeuticsmd Inc , Investor Relations Nichol , Chief Executive Officer Robert Finizio , Chief Financial Officer Jamesd Arecca , Chief Commercial Officer Dawn Halkuff , Chief Strategy , Performance Officer Mitchell , Just Say , Performance Officer , Nuvaring Generic , Stifel Financial ,